[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100593805":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":26,"locations":25,"responsibleParty":32,"collaborators":25,"id":34,"slug":25,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":37,"acronym":38,"eligibilityCriteria":39,"healthyVolunteers":35,"sex":40,"minAge":41,"maxAge":25,"enrollmentInfo":42,"targetDuration":25,"studyType":45,"phases":46,"briefSummary":48,"conditions":49,"keywords":25,"overallStatus":51,"whyStopped":25,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":25},{"fullName":5,"class":6},"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"BL Predictor","EXPERIMENTAL","Parallel,non-inferiority, randomised control trial will be conducted in patients with a low-risk score stratified by BL-Predictor",[13],"Diagnostic Test: BL-Predicter",{"label":15,"type":16,"description":17,"interventionNames":18},"control","ACTIVE_COMPARATOR","St followed, if negative,by a fractioned dose DTP wirth 30 min interval between doses: 25%-25%-50% of the maximun dose",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DIAGNOSTIC_TEST","BL-Predicter","To Clinically validate the BL-Predictor toll by a randomised conytrolled ttrial",[9,15],null,[27],{"name":28,"role":29,"phone":30,"phoneExt":25,"email":31},"Marina Labella Alvarez MLB Bonilla Toyos","CONTACT","+34951032058","elvira.bonilla@ibima.eu",{"type":33,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100593805",false,"NCT07011212","In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping","Allergy","Inclusion Criteria:\n\n* signed informed consnet\n\nExclusion Criteria:\n\n* Use of immunomodulators, antihistamines and corticosteroids","ALL","14 Years",{"count":43,"type":44},332,"ESTIMATED","INTERVENTIONAL",[47],"NA","Testing a clinical decision tool (BL-Predictor)",[50],"Drug Allergy","NOT_YET_RECRUITING","2025-05-30",{"date":54,"type":55},"2025-06-08","ACTUAL",{"date":57,"type":44},"2025-07",{"date":59,"type":44},"2027-07",{"name":5,"class":6}]